BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 05, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

OMS302 regulatory update

Omeros submitted an NDA to FDA for use of OMS302 in patients undergoing intraocular lens...

Read the full 55 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >